[go: up one dir, main page]

WO2013056048A3 - Nutritional products comprising beta-alanine - Google Patents

Nutritional products comprising beta-alanine Download PDF

Info

Publication number
WO2013056048A3
WO2013056048A3 PCT/US2012/059954 US2012059954W WO2013056048A3 WO 2013056048 A3 WO2013056048 A3 WO 2013056048A3 US 2012059954 W US2012059954 W US 2012059954W WO 2013056048 A3 WO2013056048 A3 WO 2013056048A3
Authority
WO
WIPO (PCT)
Prior art keywords
alanine
beta
nutritional products
nutritional
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2012/059954
Other languages
French (fr)
Other versions
WO2013056048A2 (en
Inventor
Timothy M. CHAPMAN
Normanella T. Dewille
Douglas J. WEARLY
Jeffrey H. Baxter
Kelley J. LOWE
Terrance B. MAZER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of WO2013056048A2 publication Critical patent/WO2013056048A2/en
Publication of WO2013056048A3 publication Critical patent/WO2013056048A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Disclosed are nutritional products, and particularly, nutritional liquids, comprising beta-alanine. The nutritional products not only provide benefits for individuals concerned with muscle health and functionality, but can also be administered without the adverse side-effect of paresthesia caused by ingestion of beta-alanine.
PCT/US2012/059954 2011-10-13 2012-10-12 Nutritional products comprising beta-alanine Ceased WO2013056048A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161546978P 2011-10-13 2011-10-13
US61/546,978 2011-10-13

Publications (2)

Publication Number Publication Date
WO2013056048A2 WO2013056048A2 (en) 2013-04-18
WO2013056048A3 true WO2013056048A3 (en) 2013-07-18

Family

ID=47046895

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/059954 Ceased WO2013056048A2 (en) 2011-10-13 2012-10-12 Nutritional products comprising beta-alanine

Country Status (2)

Country Link
TW (1) TW201320908A (en)
WO (1) WO2013056048A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
EP1968564B1 (en) 2005-12-19 2015-09-16 Abbott Laboratories Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type 1 and type 2 cytokine production
WO2013170189A1 (en) * 2012-05-11 2013-11-14 Abbott Laboratories Combination of beta - hydroxy - beta - methylbutyrate and beta - alanine for increasing muscle blood flow
WO2014117176A1 (en) * 2013-01-28 2014-07-31 Lopez Hector L Methods of improving tolerability, pharmacodynamics, and efficacy of b-alanine and use therefor
WO2021236440A1 (en) * 2020-05-20 2021-11-25 Advanced Food Concepts, Inc. Athletic performance enhancement composition using menthol
EP4236945A1 (en) * 2020-10-30 2023-09-06 Société des Produits Nestlé S.A. Compositions containing nicotinamide and vitamin b6 and methods of using such compositions for promoting muscle growth
EP4236948A1 (en) * 2020-10-30 2023-09-06 Société des Produits Nestlé S.A. Compositions containing nicotinamide and vitamin b6 and methods of using such compositions for treating sarcopenia and frailty
CA3195509A1 (en) * 2020-10-30 2022-05-05 Pascal STUELSATZ Compositions containing nicotinamide and vitamin b6 and methods of using such compositions for rehabilitation
US20230390263A1 (en) * 2020-10-30 2023-12-07 Societe Des Produits Nestle S.A. Compositions containing nicotinamide and vitamin b6 and methods of using such compositions for treating cachexia or precachexia
CN113812635B (en) * 2021-09-22 2023-12-19 大连医诺生物股份有限公司 Microencapsulated beta-alanine, preparation method and application thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3413541A1 (en) * 1984-04-11 1985-10-17 Karl Prof. Dr.med. 7302 Ostfildern Theurer Production of dietetic milk and dietetic cream
WO1995029675A1 (en) * 1994-04-29 1995-11-09 Wake Forest University Method and composition for treating renal disease and failure
WO2007073398A2 (en) * 2005-05-23 2007-06-28 Natural Alternatives International Compositions and methods for the sustained release of beta-alanine
US20090186098A1 (en) * 2008-01-18 2009-07-23 Jose Briceno Sports drink composition
WO2010112255A1 (en) * 2009-04-02 2010-10-07 Sojasun Technologies Method for manufacturing a dairy product having a reduced carbohydrate content and enriched with phospholipids, in particular choline, proteins, and calcium
WO2011094551A1 (en) * 2010-01-29 2011-08-04 Abbott Laboratories Plastic packaged nutritonal liquids comprising hmb
WO2011127039A1 (en) * 2010-04-05 2011-10-13 Abbott Laboratories Shelf stable nutritional liquids comprising beta alanine

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3413541A1 (en) * 1984-04-11 1985-10-17 Karl Prof. Dr.med. 7302 Ostfildern Theurer Production of dietetic milk and dietetic cream
WO1995029675A1 (en) * 1994-04-29 1995-11-09 Wake Forest University Method and composition for treating renal disease and failure
WO2007073398A2 (en) * 2005-05-23 2007-06-28 Natural Alternatives International Compositions and methods for the sustained release of beta-alanine
US20090186098A1 (en) * 2008-01-18 2009-07-23 Jose Briceno Sports drink composition
WO2010112255A1 (en) * 2009-04-02 2010-10-07 Sojasun Technologies Method for manufacturing a dairy product having a reduced carbohydrate content and enriched with phospholipids, in particular choline, proteins, and calcium
WO2011094551A1 (en) * 2010-01-29 2011-08-04 Abbott Laboratories Plastic packaged nutritonal liquids comprising hmb
WO2011127039A1 (en) * 2010-04-05 2011-10-13 Abbott Laboratories Shelf stable nutritional liquids comprising beta alanine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BOYD L C ET AL: "Isolation and Characterization of Whey Phospholipids", JOURNAL OF DAIRY SCIENCE, AMERICAN DAIRY SCIENCE ASSOCIATION, US, vol. 82, no. 12, 1 December 1999 (1999-12-01), pages 2550 - 2557, XP027111251, ISSN: 0022-0302, [retrieved on 19991201] *
LIVNEY ET AL: "Milk proteins as vehicles for bioactives", CURRENT OPINION IN COLLOID AND INTERFACE SCIENCE, LONDON, GB, vol. 15, no. 1-2, 1 April 2010 (2010-04-01), pages 73 - 83, XP026896481, ISSN: 1359-0294, [retrieved on 20091120], DOI: 10.1016/J.COCIS.2009.11.002 *

Also Published As

Publication number Publication date
WO2013056048A2 (en) 2013-04-18
TW201320908A (en) 2013-06-01

Similar Documents

Publication Publication Date Title
WO2013056048A3 (en) Nutritional products comprising beta-alanine
HK1211231A1 (en) Exendin-4 derivatives
EP2789246A4 (en) AGENT IMPROVING TASTE AND FOOD OR DRINK CONTAINING THE SAME
WO2011110918A8 (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
ZA201207940B (en) Enhancing the nutritional value of food products
PH12013501292A1 (en) Nutritional products comprising calcium beta-hydroxy-beta methylbutyrate and conjugated linoleic acid
GB201210699D0 (en) Nutritional food
PL2739615T3 (en) Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament
AU346731S (en) 1. Chair without arms 2. chair with arms
BR112015002666A2 (en) Method for producing a sweet juice composition, sweet juice composition, food, beverage, pharmaceutical or dietary supplement composition and use of a sweet juice composition.
HK1208993A1 (en) Obesity animal model and methods for making and using thereof
PH12015501334A1 (en) Milk-based nutritional compositions containing lactoferrin and uses thereof
SG11201504153QA (en) Beverage with heart aid functional ingredients and process thereof
WO2012159092A3 (en) Medical food for cognitive decline
PH12014502071A1 (en) Beta-hydroxy-beta-methylbutyric acid for imrpoving glucose tolerance
EP2709455A4 (en) Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives
EA201291294A1 (en) IZOMALTHLOSE FOR APPLICATION TO ENHANCE MENTAL ACTIVITY
Tullis The death of preschool
SG11201406814QA (en) Puffed snack food and infused puffed snack food
BR112013033127A2 (en) dietary supplement, dietary composition and dosage form
WO2014003950A3 (en) Selenium containing nucleosides as nutritional supplements
EP2842433A4 (en) FOOD FOR NUTRITIONAL THERAPY FOR AIDS
MX345908B (en) Edible energy composition.
WO2012146736A8 (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
WO2012119049A3 (en) Nutritional compositions comprising prune extract and bioavailable curcumin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12775422

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12775422

Country of ref document: EP

Kind code of ref document: A2